Health benefits of an adverse events reporting system for chronic pain patients using long‐term opioids

Safety data from long‐term opioid therapy in the real world has been poorly studied in chronic non‐cancer pain (CNCP). The aim was to design a pharmacovigilance data recording system and assess whether participation in this recording system improves pain management, enhancing patient′s health status.

• Publication year

  2018

• Venue

  Acta Anaesthesiologica Scandinavica

• Publication date

  2018-08-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/aas.13243PMID 30109708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Direct Patient Reporting of Adverse Drug Reactions

  2020cited by this paper
• Direct Patient Reporting of Adverse Drug Reactions

  2019cited by this paper
• Stockley’s Drug Interactions

  2018cited by this paper
• Long‐term opioid therapy for chronic non‐cancer pain in Germany

  2016cited by this paper
• Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study—study protocol

  2016cited by this paper
• Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department.

  2016cited by this paper
• Using opioids in general practice for chronic non‐cancer pain: an overview of current evidence

  2016cited by this paper
• Using opioids in general practice for chronic non‐cancer pain: an overview of current evidence

  2016cited by this paper
• Relative utility of a visual analogue scale vs. a six-point Likert scale in the measurement of global subject outcome in patients with low back pain receiving physiotherapy.

  2015cited by this paper
• The depth, duration, and degree of outpatient pediatric polypharmacy in Colorado fee‐for‐service Medicaid patients

  2015cited by this paper
• Survey of patients’ experiences and their certainty of suspected adverse drug reactions

  2015cited by this paper
• Preventability of adverse effects of analgesics: analysis of spontaneous reports

  2015cited by this paper
• Assessing pain intensity with the visual analog scale: A plea for uniformity

  2014cited by this paper
• Survey of European patients assessing their own noncancer chronic pain: results from Spain

  2013cited by this paper
• Opioid Therapy Pharmacogenomics for Noncancer Pain: Efficacy, Adverse Events, and Costs

  2013cited by this paper
• Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain

  2013cited by this paper
• How Do Patients Contribute to Signal Detection?

  2013cited by this paper
• Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

  2012cited by this paper
• How frequently are contraindicated or warned against combinations of drugs prescribed to patients receiving long‐term opioid therapy for chronic pain?

  2012cited by this paper
• Pharmacoeconomic impact of adverse events of long-term opioid treatment for the management of persistent pain.

  2011cited by this paper
• European survey of chronic pain patients: results for Germany

  2011cited by this paper
• Minimising the misuse of oxycodone and other pharmaceutical opioids in Australia

  2011cited by this paper
• Pharmacoeconomic Impact of Adverse Events of Long-Term Opioid Treatment for the Management of Persistent Pain

  2011cited by this paper
• Access to pain treatment as a human right

  2010cited by this paper
• The effects of opioids and opioid analogs on animal and human endocrine systems.

  2010cited by this paper
• Assessing and treating pain in hospices: current state of evidence-based practices.

  2010cited by this paper
• Guidelines for submitting adverse event reports for publication.

  2009cited by this paper
• The Impact of Opioids on the Endocrine System

  2009cited by this paper
• Oral opioid use alters DNIC but not cold pain perception in patients with chronic pain – New perspective of opioid‐induced hyperalgesia

  2008cited by this paper
• Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

  2008cited by this paper
• Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.

  2008cited by this paper
• Adverse Effects of Transdermal Opiates Treating Moderate-Severe Cancer Pain in Comparison to Long-Acting Morphine: A Meta-Analysis and Systematic Review of the Literature

  2008cited by this paper
• National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.

  2008cited by this paper
• Opioid analgesia: perspectives on right use and utility.

  2007cited by this paper
• Adverse Effects of Opioids on the Central Nervous Systems of Palliative Care Patients

  2007cited by this paper
• Guidelines for submitting adverse event reports for publication.

  2007cited by this paper
• Sexual function in chronic kidney disease.

  2007cited by this paper
• National surveillance of emergency department visits for outpatient adverse drug events.

  2006cited by this paper
• Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug Reactions

  2005cited by this paper
• Patients’ role in reporting adverse drug reactions

  2004cited by this paper
• Potent opioids for chronic musculoskeletal pain: flying blind?

  2004cited by this paper
• Efficacy and safety of transdermal fentanyl and sustained-release oral morphine in patients with cancer and chronic non-cancer pain

  2004cited by this paper
• Patients' role in reporting adverse drug reactions.

  2004cited by this paper
• Patient reporting of adverse drug reactions: useful information for pain management?

  2003cited by this paper
• Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review.

  2003cited by this paper
• Identifying and addressing medical errors in pain mismanagement.

  2001cited by this paper
• Flying blind

  1997cited by this paper
• Drug-Related Hospital Admissions

  1993cited by this paper
• A method for estimating the probability of adverse drug reactions

  1981cited by this paper
• Toward the operational identification of adverse drug reactions

  1977cited by this paper
• International Drug Monitoring the Role of the Hospital — A WHO Report

  1970cited by this paper

• Using a Two-Steps Clustering and PCA Analysis for Stratified Chronic Non-Cancer Pain Care: A Retrospective Cross-Sectional Study

  2025cites this paper
• Predictive Model for Opioid Use Disorder in Chronic Pain: A Development and Validation Study

  2024cites this paper
• Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach.

  2024cites this paper
• Fascial manipulation for musculoskeletal disorders: A scoping review.

  2024cites this paper
• Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences

  2023cites this paper
• Sex Differences in Opioid Response Linked to OPRM1 and COMT genes DNA Methylation/Genotypes Changes in Patients with Chronic Pain

  2023cites this paper
• Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study

  2022cites this paper
• Oxycodone/naloxone versus tapentadol in real-world chronic non-cancer pain management: an observational and pharmacogenetic study

  2022cites this paper
• Sex-Differences in Pain and Opioid Use Disorder Management: A Cross-Sectional Real-World Study

  2022cites this paper
• Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study

  2022cites this paper
• Non-pharmacological therapy in chronic musculoskeletal pain

  2022cites this paper
• Global Pain State Questionnaire: Reliability, Validity, and Gender Gap

  2021cites this paper
• Sex Bias and Genotype Influence on Opioid Safety Profile in Chronic Low Back Pain

  2020cites this paper
• Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study

  2019cites this paper
• Tramadol-associated hallucinations: a systematic review and narrative synthesis of their pathophysiology, diagnosis, and treatment

  2019cites this paper
• Gender based differences, pharmacogenetics and adverse events in chronic pain management

  2019cites this paper